The resources available below may help you navigate the access and reimbursement process for Bristol Myers Squibb CAR T cell therapies 

Coding and billing for CAR T cell therapies will vary based on patient’s condition, provided services, payer-specific requirements, and selected site/setting of care. It is critical to confirm specific payer requirements prior to claim submission in order to avoid processing delays or denials.

 ^{CAR=chimeric antigen receptor; R/R=relapsed or refractory.}

_{This information is provided for educational purposes only. Bristol Myers Squibb cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care and is subject to frequent change. It is the sole responsibility of the healthcare provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.}